Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MULTICENTER ACTUAL USE AND COMPLIANCE STUDY OF IBUPROFEN 600 MG IMMEDIATE RELEASE/EXTENDED RELEASE TABLETS AMONG TARGETED (AT-RISK) CONSUMERS IN A SIMULATED OVER-THE-COUNTER ENVIRONMENT

NCT03722238 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03722238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03722238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MULTICENTER ACTUAL USE AND COMPLIANCE STUDY OF IBUPROFEN 600 MG IMMEDIATE RELEASE/EXTENDED RELEASE TABLETS AMONG TARGETED (AT-RISK) CONSUMERS IN A SIMULATED OVER-THE-COUNTER ENVIRONMENT
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
December 27, 2018
Completion date
October 28, 2019
Enrollment
613 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

pain